# Vogenx Inc (VOGX)

Source: https://www.quantisnow.com/company/VOGX
Generated: 2026-11-10T22:10:21.560Z

- Ticker: VOGX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2026
- SEC CIK: 0001903784

## About

Vogenx, Inc. (Nasdaq:VOGX) is a clinical-stage biopharmaceutical company based in Raleigh, North Carolina, focused on the discovery and development of novel therapeutics for the treatment of serious metabolic and gastrointestinal diseases with high unmet medical need. The Company is developing its lead product candidate, mizagliflozin, for post-bariatric hypoglycemia, gastroparesis and GIP-dependent Cushing's Syndrome.

## Latest VOGX news and filings

- 2026-11-06 22:24 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Vogenx Inc](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-vogenx-inc-6779568)
- 2026-11-06 11:47 UTC [SEC Form 8-K] [Vogenx Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vogenx-inc-filed-sec-form-8-k-results-of-operations-and-6777859)
- 2026-11-06 11:30 UTC [Market Insight] [Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights](https://www.quantisnow.com/insight/vogenx-reports-third-quarter-2026-financial-results-and-business-highlights-6777817)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/VOGX
- Earnings history: https://www.quantisnow.com/earnings/VOGX
- Dividend history: https://www.quantisnow.com/dividends/VOGX
- Insider transactions: https://www.quantisnow.com/insiders/VOGX
- Options chain: https://www.quantisnow.com/options/VOGX
- SEC 8-K filings only: https://www.quantisnow.com/company/VOGX/8-k
- RSS and alerts for VOGX: https://www.quantisnow.com/docs/rss-feeds.md